AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
Key Details
- 1Researchers used machine learning to analyze cancer incidence and mortality data from 185 countries.
- 2Study incorporated metrics on radiotherapy access, health system structure, and economic indicators.
- 3Radiotherapy access, universal health coverage, and national wealth repeatedly emerged as top factors for improved survival.
- 4The SHAP-based model provides country-specific roadmaps for policy investment priorities.
- 5An interactive tool allows users to view and compare readiness or gaps for their own country.
- 6The study is published in Annals of Oncology (Jan 2026).
Why It Matters
Radiotherapy access is a major imaging-related determinant of cancer outcomes globally; this AI-driven framework offers targeted, actionable guidance to policymakers and health leaders, promising more efficient allocation of imaging and treatment resources.
Source
EurekAlert
Related News
•EurekAlert
AI Model BIOPREVENT Predicts Complications in Stem Cell Transplant Patients
A new AI tool, BIOPREVENT, predicts serious post-transplant complications months before symptoms appear using blood biomarkers and clinical data.
•EurekAlert
New Review Explores Cancer-Inflammation Link and Imaging AI in Precision Therapy
A recent review highlights inflammation’s dual role in cancer progression and how emerging tools like AI and imaging biomarkers are enhancing personalized immunotherapy.
•EurekAlert
CNN-Based AI Enhances Lung Nodule Detection on CT Scans
A CNN-based system achieved high accuracy in detecting and classifying pulmonary nodules using LIDC-IDRI CT data.